作者
Beatríz Salazar,Maria Agudelo,Carlos Andrés Rodríguez,Restrepo, Andrea,Andrés Felipe Zuluaga,Ómar Vesga
摘要
Streptococcus pneumoniae leads the etiology of acute respiratory tract infection and invasive disease, killing each year more than a million children under 5 years of age. Although this organism was susceptible to penicillin for almost half a century, the past two decades have witnessed an alarming increase in the number of strains resistant to this and other antibiotics. In Colombia, penicillin resistance among pediatric invasive isolates increased from 10 to 56% between 1994 and 2001. Although excellent animal models of pneumonia and sepsis are available for penicillin-susceptible strains, models of pneumonia with PRSP lack reproducibility, mainly because PRSP strains display low virulence in rodents. In the present study, we addressed this particular problem to obtain a model of PRSP pneumonia that is simple, practical, reliable and reproducible for in vivo evaluation of antibiotics. Fundamental for success with this model was the development of a supplemented culture medium to optimize bacterial growth in the infecting inoculum, and its further modification to enhance virulence and induce an infection closely resembling pneumococcal pneumonia in humans. Background: experimental murine pneumonia can be induced with most susceptible strains, but results with PRSP are much harder to reproduce. By optimizing in vitro growth of PRSP, we developed a reproducible murine model of pneumonia, useful to evaluate in vivo efficacy of antibiotics. Methods: we used 6 clinical strains of PRSP representing serotypes 19F, 9V, 14 and 6B as well as S. pneumoniae ATCC 49619 as standard strain. After optimization of culture conditions to obtain maximal growth of PRSP, neutropenic animals were infected by nasal instillation of 50 µL log-phase bacteria. MPF Udea:ICR(CD-1) female mice were 6 weeks-old and weighted 25±2g when inoculated with 10 7.7-8.4 log10 CFU/mL of each strain. Groups of 3 mice were sacrificed and their lungs removed at 1, 2, 4, 6, 12, 14, 16, 24, 36, and 48 h after infection in order to determine the dynamics of bacterial infection by appropriate homogenization, dilution, serial plating, and culture on TSA 5% blood agar. A second model, in which 50% of the inoculum was replaced by 10% porcine mucin, was similarly evaluated. Results: culture optimization led to growth of 9-10 log10 CFU/mL, avoiding autolysis. One hour after infection, mice had 6.20-7.79 log10 CFU/g of lung, a count that decreased to 3.6-7.6 log10 CFU/g at 17±5 h (nadir) and then increased up to 6.8-9.6 log10 CFU/g at 42±6 h (zenith), giving a net growth of 2.0-3.2 logs in 25 h. Histopathology confirmed pneumonia in all animals with all PRSP strains, but most mice recovered from the infection after 5 days. Mucin enhanced the virulence of all PRSP strains by transforming the model into a uniformly lethal pneumonia by 29 to 79 hours, with bacterial dissemination to all vital organs. Conclusion: reproducible induction of PRSP pneumonia was attained with diverse clinical strains. Virulence enhancement with 10% porcine mucin allowed a lethal pneumonia model.